Article info

Original research
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer

Authors

  • Shujing Wang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Hua Zhu Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Yingjie Li Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Jin Ding Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Feng Wang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Lixin Ding Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Xinyu Wang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Jun Zhao Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Yan Zhang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Yunfeng Yao Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Tong Zhou Department of Cell Biology and Divisions of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Nan Li Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Aiwen Wu Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Zhi Yang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Nan Li; rainbow6283{at}sina.com; Professor Aiwen Wu; wuaw{at}sina.com; Professor Zhi Yang; pekyz{at}163.com
View Full Text

Citation

Wang S, Zhu H, Li Y, et al
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer

Publication history

  • Accepted June 25, 2021
  • First published July 22, 2021.
Online issue publication 
July 22, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.